Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Itraconazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Recipient : George R Thompson
Deal Size : Inapplicable
Deal Type : Inapplicable
SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 22, 2021
Lead Product(s) : Itraconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Recipient : George R Thompson
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcipotriol
Therapeutic Area : Dermatology
Study Phase : Phase I
Recipient : Tulane University
Deal Size : Inapplicable
Deal Type : Inapplicable
Combination Topical Therapy for Treatment of Scalp Actinic Keratoses
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 24, 2019
Lead Product(s) : Calcipotriol
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Recipient : Tulane University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Halobetasol
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
June 20, 2019
Lead Product(s) : Halobetasol
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Trifarotene
Therapeutic Area : Dermatology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 13, 2018
Lead Product(s) : Trifarotene
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ivermectin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Biorasi
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 09, 2017
Lead Product(s) : Ivermectin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Biorasi
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Permethrin
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Biorasi
Deal Size : Inapplicable
Deal Type : Inapplicable
Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 01, 2016
Lead Product(s) : Permethrin
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Biorasi
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Itraconazole
Therapeutic Area : Hematology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioavailability Study of Lozanocâ„¢ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 29, 2016
Lead Product(s) : Itraconazole
Therapeutic Area : Hematology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Itraconazole
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 04, 2015
Lead Product(s) : Itraconazole
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcipotriol
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : GSK
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 23, 2012
Lead Product(s) : Calcipotriol
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : GSK
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcipotriol
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : GSK
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 26, 2012
Lead Product(s) : Calcipotriol
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : GSK
Deal Size : Inapplicable
Deal Type : Inapplicable